Actively Recruiting
30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
Led by Komfo Anokye Teaching Hospital · Updated on 2025-08-03
150
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital
CONDITIONS
Official Title
30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and above
- Diagnosed with heart failure
- Heart failure classified as NYHA Class II-IV
- Provided informed consent to participate
You will not qualify if you...
- Heart failure classified as NYHA Class I
- Patients without access to a mobile phone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Komfo Anokye Teaching Hospital
Kumasi, Ashanti Region, Ghana
Actively Recruiting
Research Team
S
SOLOMON GYABAAH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here